The latest closing stock price for GT Biopharma as of January 21, 2025 is 2.31.
An investor who bought $1,000 worth of GT Biopharma stock at the IPO in 2021 would have $-554 today, roughly -1 times their original investment - a -18.28% compound annual growth rate over 4 years.
The all-time high GT Biopharma stock closing price was 18.96 on June 02, 2021.
The GT Biopharma 52-week high stock price is 10.66, which is 361.5% above the current share price.
The GT Biopharma 52-week low stock price is 0.17, which is 92.6% below the current share price.
The average GT Biopharma stock price for the last 52 weeks is 3.02.
An investor who bought $1,000 worth of GT Biopharma stock at the IPO in 2021 would have $-554 today, roughly -1 times their original investment - a -18.28% compound annual growth rate over 4 years.
The all-time high GT Biopharma stock closing price was 18.96 on June 02, 2021.
The GT Biopharma 52-week high stock price is 10.66, which is 361.5% above the current share price.
The GT Biopharma 52-week low stock price is 0.17, which is 92.6% below the current share price.
The average GT Biopharma stock price for the last 52 weeks is 3.02.